27 Aug 2019
// Andrew Dunn BIOPHARMADIVE
https://www.biopharmadive.com/news/zogenix-buys-modis-for-250m-building-out-rare-disease-pipeline/561681/
27 Jun 2019
// Mark Terry BIOSPACE
https://www.biospace.com/article/zogenix-given-go-ahead-to-resubmit-fintepla-to-fda-for-dravet-syndrome/